InfiCure Bio is a life science company focusing on preclinical development and validation of drugs that target chronic inflammatory and fibrotic conditions. The company offers pharmaceutical companies to test their new anti-inflammatory/anti-fibrotic drugs in the unique preclinical model.
Employees: 1-10
Founded date: 2015
Investors 3
| Date | Name | Website |
| - | Almi Inves... | almi.se |
| - | Northern L... | northernli... |
| - | Umeå Biote... | ubi.se/ |
Mentions in press and media 1
| Date | Title | Description |
| 02.08.2023 | Startup Showcase: InfiCure Bio – Trailblazing Research | In the dynamic world of biotechnology, the freshest innovator to step into the spotlight is InfiCure Bio. Headquartered in the thriving life sciences hub of Umeå, Sweden, InfiCure Bio represents a novel approach to fibrosis and inflammation... |